Trademark Overview
On Tuesday, August 12, 2025, a trademark application was filed for TOTAL ANCILLARY with the United States Patent and Trademark Office. The USPTO has given the TOTAL ANCILLARY trademark a serial number of 99333692. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, December 30, 2025. This trademark is owned by Total Ancillary Management LLC. The TOTAL ANCILLARY trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Advertising, Business and Retail Services, Transportation & Storage Services, and Computer & Software Services & Scientific Services categories with the following description:
Business advisory services in the field of healthcare for healthcare providers and surgical facilities concerning procurement, compliance, and cost-efficiency in the use of amniotic and extracellular matrix-based therapies; Advertising, marketing, and promotion services in the field of tissue-based medical innovations, including advertising placement, brand identity development, and dissemination of product information to healthcare institutions.; On-line ordering services featuring biological grafts and wound care products; Distributorship services and on-line wholesale and retail store services featuring advanced wound care products, namely, dehydrated human amniotic membrane allografts and skin substitutes, including dual-layer amnion patches and amnion-chorion membranes; Business management and consulting services in the field of regenerative medicine product commercialization and distribution
Downloadable software for healthcare management, benefits verification, supply chain management, revenue cycle management, patient data analytics, and compliance tracking in the field of wound care and skin substitute therapies
Providing on-line non-downloadable software for healthcare management, namely, software that integrates with electronic health record (EHR) and electronic medical record (EMR) platforms to facilitate benefits verification, supply chain management, revenue cycle management, patient data analytics, and compliance tracking in the field of wound care and skin substitute therapies.
Warehousing services, namely, storage, distribution, pick-up, packing, and shipping of biological grafts and wound care products; Distribution services, namely, delivery of dehydrated human amniotic membrane allografts and skin substitutes, including dual-layer amnion patches and amnion-chorion membranes; Transport, delivery, packaging, and storage of human tissue allografts, amniotic membranes, biologic grafts, and surgical barrier products for use in orthopedic, wound care, and restorative medical procedures; inventory control and fulfillment services for amniotic and extracellular matrix-based therapies
